Gamco Investors INC. ET AL Raises Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Gamco Investors INC. ET AL grew its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 11.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 28,086 shares of the medical instruments supplier’s stock after purchasing an additional 2,936 shares during the period. Gamco Investors INC. ET AL owned approximately 0.12% of ICU Medical worth $3,014,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in ICUI. Vanguard Group Inc. boosted its position in shares of ICU Medical by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock worth $263,226,000 after buying an additional 11,991 shares in the last quarter. Schroder Investment Management Group boosted its position in shares of ICU Medical by 35.8% in the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock worth $43,272,000 after buying an additional 114,344 shares in the last quarter. WCM Investment Management LLC boosted its position in shares of ICU Medical by 5.8% in the 1st quarter. WCM Investment Management LLC now owns 256,946 shares of the medical instruments supplier’s stock worth $27,575,000 after buying an additional 14,138 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of ICU Medical by 4.3% in the 4th quarter. Dimensional Fund Advisors LP now owns 220,624 shares of the medical instruments supplier’s stock worth $22,005,000 after buying an additional 9,196 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of ICU Medical in the 4th quarter worth about $20,669,000. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on ICUI. Raymond James upgraded shares of ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 price objective on the stock in a research report on Monday, June 17th. Needham & Company LLC began coverage on shares of ICU Medical in a research report on Friday, June 21st. They issued a “hold” rating on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $127.00.

Insider Activity

In other news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the transaction, the insider now owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, COO Christian B. Voigtlander sold 12,539 shares of the stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ben Sousa sold 2,000 shares of the stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the sale, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The disclosure for this sale can be found here. Insiders sold a total of 14,839 shares of company stock valued at $1,546,014 in the last 90 days. 6.70% of the stock is currently owned by insiders.

ICU Medical Price Performance

ICUI stock traded up $3.56 during trading on Friday, hitting $128.03. The stock had a trading volume of 197,617 shares, compared to its average volume of 383,935. The company’s 50 day moving average price is $115.90 and its two-hundred day moving average price is $105.55. ICU Medical, Inc. has a 1-year low of $78.28 and a 1-year high of $180.73. The stock has a market cap of $3.12 billion, a price-to-earnings ratio of -52.26 and a beta of 0.69. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61.

ICU Medical (NASDAQ:ICUI) last announced its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.06. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The firm had revenue of $566.66 million during the quarter, compared to the consensus estimate of $553.15 million. On average, sell-side analysts forecast that ICU Medical, Inc. will post 3.5 EPS for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.